This was the stock's fifth consecutive day of losses.

About $3.8 billion in Bitcoin [BTC] and Ethereum [ETH] Options expired yesterday, suggesting potential volatility. Such ...

This was the stock's second consecutive day of losses.

Analysts have set 12-month price targets for CME Group, revealing an average target of $276.38, a high estimate of $305.00, ...

Appalaches Capital, an investment management firm, released its first quarter 2025 investor letter. A copy of the letter can ...

CME Group's strong performance and market-agnostic revenues support its resilience. Find out why CME stock is a Hold.

CME Group Inc ... conditions and analyst perspectives as of that date. Gain an edge in your investment decisions with InvestingPro’s in-depth analysis and exclusive insights on CME.

For investors seeking deeper insights into CME’s performance ... In other recent news, CME Group reported its first-quarter 2025 earnings, surpassing analyst expectations with an adjusted ...

CME Group thrives on market volatility ... CME is worth buying. Analyst’s Disclosure:I/we have a beneficial long position in the shares of CME either through stock ownership, options, or ...

An in-depth analysis of recent analyst actions unveils how financial experts perceive CME Group. The following ... some analysts extend their insights by offering predictions for key metrics ...

The latest price target for CME Group (NASDAQ:CME) was reported by Oppenheimer on June 4, 2025. The analyst firm set a price target for $300.00 expecting CME to rise to within 12 months (a ...

CME Group (NASDAQ:CME – Get Free Report) had its target price lifted by Oppenheimer from $269.00 to $279.00 in a research report issued to clients and investors on Friday,Benzinga reports.